Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 ,inter alia, to consider and approve the audited financial results ....
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has informed the stock exchanges that its Board of Directors will meet on Saturday, May 10, 2025. The main items on the agenda are approval of the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025. The Board will also consider recommending a dividend, if any, for the financial year ended March 31, 2025. The company's trading window has been closed since April 1, 2025 and will remain closed until May 12, 2025 to prevent insider trading ahead of the results announcement.
This is a routine advance notice ahead of the FY25 results and any potential dividend announcement on May 10. Investors should watch for the actual results and dividend decision on that date for material information.